Concepedia

Cynthia Serdikoff

CS

Statistics

Publications

8

Citations

567

H-Index

8

Active since

1999

Affiliations

University of Pittsburgh(Current)

University of Pennsylvania

Cynthia Serdikoff is an author at University of Pittsburgh specializing in jak inhibitor therapy, jak inhibitors, and medicine.

Publications per year

1999–2012

8

Publications

8

Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders

Elizabeth O. Hexner, Cynthia Serdikoff, Mahfuza Jan et al. · Blood · 2007 · 252 citations · Full text

, , +12

A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis

Kristine L. Stump, Lily Lu, Paweł Dobrzański et al. · Arthritis Research & Therapy · 2011 · 76 citations · Full text

, , +17

Depletion of Autoreactive Plasma Cells and Treatment of Lupus Nephritis in Mice Using CEP-33779, a Novel, Orally Active, Selective Inhibitor of JAK2

Lily Lu, Kristine L. Stump, Nate H. Wallace et al. · The Journal of Immunology · 2011 · 75 citations · Full text

, , +16

A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-<i>a</i>]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779

Benjamin J. Dugan, Diane E. Gingrich, Eugen F. Mesaros et al. · Journal of Medicinal Chemistry · 2012 · 62 citations · Full text

, , +14

Characterization of an oligopeptide transporter in renal lysosomes

Xiaodong Zhou, Manikkavasagar Thamotharan, Archana Gangopadhyay et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2000 · 43 citations

, , +14

1–5 of 8